Esomeprazole Market is bound to Exhibit Comprehensive Growth - DataM Intelligence
The "Global Esomeprazole Market" is predicted to reach at a high CAGR during the forecast period (2021-2028).
(EMAILWIRE.COM, October 19, 2021 )
Market Overview
Esomeprazole belongs to the proton pump inhibitors class of drugs that decreases the amount of acid produced in the stomach by obstructing H+/K+-ATPase in the stomach cells. It is a compound isomer omeprazole that is taken in the magnesium salt form. It is sold under the name of 'Nexium' and used to treat Erosive Esophagitis, Gastroesophageal reflux disease, Peptic ulcer, and Zollinger Ellison Syndrome route of administration of esomeprazole is oral or injected directly into the vein.
Moreover, it has many side effects such as headache, constipation, dry mouth, abdominal pain, and some major side effects are Angioedema, Pneumonia and Clostridium infection. It is used for a safe pregnancy and also used post-pregnancy by females during breastfeeding. It is used in combination with antibiotics like amoxicillin and clarithromycin to prevent ulcers caused by Helicobacter pylori bacteria.
View full report: https://www.datamintelligence.com/research-report/esomeprazole-market
Market Dynamics
The global esomeprazole market growth is driven by the growing cases of gastroesophageal reflux disease (GERD), and Increase in the adoption of drug delivery systems and successful launch of new products, Low treatment cost, readily availability and these drugs are sold without any prescription are the major factors.
Growing cases of gastroesophageal reflux disease (GERD), is expected to drive the global Esomeprazole market growth.
Gastroesophageal reflux disease is a chronic and pervasive disorder. GERD usually occurs when stomach acid frequently flows back into the tube connecting the mouth and stomach (esophagus). It is mostly found in the middle-aged and geriatric populations.
As per the report of “World Ageing Population, 2019”, approximately 702.9 million geriatric population was reported globally. Moreover, the combination of non-steroidal anti-inflammatory (NSAID) drugs and proton pump inhibitors decreases the risk of lower gastrointestinal bleeding. Hence, it is expected to rise the demand for esomeprazole market growth.
Minor & Major side effects of drugs are likely to hinder the market growth
Esomeprazole has many minor side effects of this drug like nausea, headaches, dry mouth, diarrhea, stomach pain, and major side effects like kidney disease, dementia, difficulty in breathing, skin rashes, Angioedema, Pneumonia, and Clostridium infection are the restricting factors of the esomeprazole market growth.
Market Segmentation:
By Dosage Type
• Vascular endothelial growth factor inhibitors (VEGF)
• Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
• Tyrosine Kinase (TKI) Inhibitors
• Immunomodulators
By Application
• Immunotherapy
• Targeted therapy
• Chemotherapy
By Distribution channels
• Hospital Pharmacies
• Retail Pharmacies
Download free sample: https://www.datamintelligence.com/download-sample/esomeprazole-market
Geographical Analysis
North America region holds the largest market share global Esomeprazole market
North America holds a large share of the global esomeprazole market. Change in lifestyle and diet habits has been a major cause of issues related to stomach acid among people in the region. As per the report by Medscape (WebMD LLC.) In the U.S., peptic ulcer disease affects approximately 4.6 million people annually, with an estimated 10% of the U.S. population exhibiting evidence of a duodenal ulcer at some time. H pylori infection accounts for 90% of duodenal ulcers and 70% to 90% of gastric ulcers.
Early symptoms and diagnosis help prevent the occurrence of the disease with the help of standard medication, such as Esomeprazole, which has also boosted the esomeprazole sodium market. In 2019, Nexium generated a revenue of $218 million from the U.S. alone.
The Asia Pacific is expected to be the fastest-growing market over the forecast period owing to the increasing prevalence rate, increasing focus on preventive care, and government initiatives promoting technological innovations. For instance, Takeda's (Millennium Pharmaceuticals, Inc) study evaluates the effect of the proton pump inhibitor (PPI) esomeprazole on the single-dose PK of orally administered TAK-906 under Phase 1 trials.
Competitive Landscape
The global esomeprazole market is highly competitive with some key competitors like Daiichi Sankyo, Astrazeneca PLC, Zydus Cadila Pharmaceuticals Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc., Torrent Pharma Inc., Amneal Pharmaceuticals LLC and Glenmark Pharmaceuticals.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the market’s growth globally. For instance, Takeda- Phase 3 Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy with Oral TAK-438 20 mg Compared to Esomeprazole 20 mg Twice Daily in Subjects with Helicobacter Pylori Infection.
Topic's you may be interested, Antinauseants Market, Achalasia Treatment Market, Antiemetic Drugs Market, Crohn’s Disease Market, Sterile Medical Packaging Market
Market Overview
Esomeprazole belongs to the proton pump inhibitors class of drugs that decreases the amount of acid produced in the stomach by obstructing H+/K+-ATPase in the stomach cells. It is a compound isomer omeprazole that is taken in the magnesium salt form. It is sold under the name of 'Nexium' and used to treat Erosive Esophagitis, Gastroesophageal reflux disease, Peptic ulcer, and Zollinger Ellison Syndrome route of administration of esomeprazole is oral or injected directly into the vein.
Moreover, it has many side effects such as headache, constipation, dry mouth, abdominal pain, and some major side effects are Angioedema, Pneumonia and Clostridium infection. It is used for a safe pregnancy and also used post-pregnancy by females during breastfeeding. It is used in combination with antibiotics like amoxicillin and clarithromycin to prevent ulcers caused by Helicobacter pylori bacteria.
View full report: https://www.datamintelligence.com/research-report/esomeprazole-market
Market Dynamics
The global esomeprazole market growth is driven by the growing cases of gastroesophageal reflux disease (GERD), and Increase in the adoption of drug delivery systems and successful launch of new products, Low treatment cost, readily availability and these drugs are sold without any prescription are the major factors.
Growing cases of gastroesophageal reflux disease (GERD), is expected to drive the global Esomeprazole market growth.
Gastroesophageal reflux disease is a chronic and pervasive disorder. GERD usually occurs when stomach acid frequently flows back into the tube connecting the mouth and stomach (esophagus). It is mostly found in the middle-aged and geriatric populations.
As per the report of “World Ageing Population, 2019”, approximately 702.9 million geriatric population was reported globally. Moreover, the combination of non-steroidal anti-inflammatory (NSAID) drugs and proton pump inhibitors decreases the risk of lower gastrointestinal bleeding. Hence, it is expected to rise the demand for esomeprazole market growth.
Minor & Major side effects of drugs are likely to hinder the market growth
Esomeprazole has many minor side effects of this drug like nausea, headaches, dry mouth, diarrhea, stomach pain, and major side effects like kidney disease, dementia, difficulty in breathing, skin rashes, Angioedema, Pneumonia, and Clostridium infection are the restricting factors of the esomeprazole market growth.
Market Segmentation:
By Dosage Type
• Vascular endothelial growth factor inhibitors (VEGF)
• Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
• Tyrosine Kinase (TKI) Inhibitors
• Immunomodulators
By Application
• Immunotherapy
• Targeted therapy
• Chemotherapy
By Distribution channels
• Hospital Pharmacies
• Retail Pharmacies
Download free sample: https://www.datamintelligence.com/download-sample/esomeprazole-market
Geographical Analysis
North America region holds the largest market share global Esomeprazole market
North America holds a large share of the global esomeprazole market. Change in lifestyle and diet habits has been a major cause of issues related to stomach acid among people in the region. As per the report by Medscape (WebMD LLC.) In the U.S., peptic ulcer disease affects approximately 4.6 million people annually, with an estimated 10% of the U.S. population exhibiting evidence of a duodenal ulcer at some time. H pylori infection accounts for 90% of duodenal ulcers and 70% to 90% of gastric ulcers.
Early symptoms and diagnosis help prevent the occurrence of the disease with the help of standard medication, such as Esomeprazole, which has also boosted the esomeprazole sodium market. In 2019, Nexium generated a revenue of $218 million from the U.S. alone.
The Asia Pacific is expected to be the fastest-growing market over the forecast period owing to the increasing prevalence rate, increasing focus on preventive care, and government initiatives promoting technological innovations. For instance, Takeda's (Millennium Pharmaceuticals, Inc) study evaluates the effect of the proton pump inhibitor (PPI) esomeprazole on the single-dose PK of orally administered TAK-906 under Phase 1 trials.
Competitive Landscape
The global esomeprazole market is highly competitive with some key competitors like Daiichi Sankyo, Astrazeneca PLC, Zydus Cadila Pharmaceuticals Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc., Torrent Pharma Inc., Amneal Pharmaceuticals LLC and Glenmark Pharmaceuticals.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the market’s growth globally. For instance, Takeda- Phase 3 Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy with Oral TAK-438 20 mg Compared to Esomeprazole 20 mg Twice Daily in Subjects with Helicobacter Pylori Infection.
Topic's you may be interested, Antinauseants Market, Achalasia Treatment Market, Antiemetic Drugs Market, Crohn’s Disease Market, Sterile Medical Packaging Market
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results